Percutaneous management of XXXX after upper gastrointestinal surgery.

@entity1 @entity32 @entity14063 @entity384 @entity1157 @entity5173 @entity292 @entity86 @entity850 @entity99
PURPOSE: This study was designed to investigate the benefit of percutaneous interventional management of @entity1 with postoperative @entity1157 on clinical outcome. Primary study endpoints were closure of the @entity1157 and duration of percutaneous transhepatic biliary drainage (PTBD) treatment. Secondary study endpoints were necessity of additional CT-guided drainage catheter placement, course of serum CRP level as parameter for @entity32 , and @entity1 ' survival. METHODS: Between January 2004 and April 2008, all @entity1 who underwent PTBD placement after upper gastrointestinal surgery were analyzed regarding site of @entity1157 and previous attempt of operative @entity1157 repair, interval between initial surgery and PTBD placement, procedural interventional management, course of @entity32 parameters, duration of PTBD therapy, PTBD-related complications, and @entity1 ' survival. RESULTS: Thirty @entity1 underwent PTBD placement for treatment of @entity86 . In 12 @entity1 (40%), PTBD was performed secondary to a surgical attempt of @entity1157 repair. Additional percutaneous @entity5173 was performed in 14 @entity1 (47%). CRP serum level decreased from 138.1    73.4 mg/l before PTBD placement to 43.5    33.4 mg/l 30 days after PTBD placement. The mean duration of @entity14063 treatment was 55.2    32.5 days in the surviving @entity1 . In one @entity1 , a delayed @entity850 of the bile duct required @entity384 . Two PTBD-related complications ( @entity292 , @entity99 ) occurred, which were successfully treated by embolization. Overall survival was 73% (22 @entity1 ). CONCLUSIONS: PTBD treatment is an effective therapy. PTBD treatment and additional CT-guided @entity5173 helped to reduce intraabdominal @entity32 , as shown by @entity32 parameters.
